| 1 |
Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol, a Thyrointegrin avß3 Antagonist as a Radio- and Chemo-Sensitizer in Pancreatic Cancer |
|
|
| Thangirala Sudha, Kavitha Godugu, Gennadi V. Glinsky, Shaker A. Mousa |
|
| Biomedicines. 2022; 10(4): 795 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
A Combination of Radiotherapy, Hyperthermia, and Immunotherapy Inhibits Pancreatic Tumor Growth and Prolongs the Survival of Mice |
|
|
| Javed Mahmood,Allen A. Alexander,Santanu Samanta,Shriya Kamlapurkar,Prerna Singh,Ali Saeed,France Carrier,Xuefang Cao,Hem D Shukla,Zeljko Vujaskovic |
|
| Cancers. 2020; 12(4): 1015 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
A Retrospective Look at Anti-EGFR Agents in Pancreatic Cancer Therapy |
|
|
| Henu K. Verma,Praveen K. Kampalli,Saikrishna Lakkakula,Gayathri Chalikonda,Lakkakula V.K.S. Bhaskar,Smaranika Pattnaik |
|
| Current Drug Metabolism. 2020; 20(12): 958 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
First experience of using combination of conformal radiation therapy with intraarterial administration of gemcitabine and nanostabilized paclitaxel in patients with locally advanced pancreatic cancer complicated by persistent chronic pain |
|
|
| A. A. Statsenko,V. E. Moiseenko,A. V. Pavlovsky,S. A. Popov,A. A. Polikarpov,E. V. Vlasova |
|
| Medical alphabet. 2020; (20): 15 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Stage IA Patients With Pancreatic Ductal Adenocarcinoma Cannot Benefit From Chemotherapy: A Propensity Score Matching Study |
|
|
| Yuchao Zhang,Gang Xu,Maozhen Chen,Qian Wei,Tengteng Zhou,Ziliang Chen,Mingyang Shen,Ping Wang |
|
| Frontiers in Oncology. 2020; 10 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
UHRF1 promotes aerobic glycolysis and proliferation via suppression of SIRT4 in pancreatic cancer |
|
|
| Qiangsheng Hu,Yi Qin,Shunrong Ji,Wenyan Xu,Wensheng Liu,Qiqing Sun,Zheng Zhang,Mengqi Liu,Quanxing Ni,Xianjun Yu,Xiaowu Xu |
|
| Cancer Letters. 2019; 452: 226 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Comparison of Radiosensitization by HDAC Inhibitors CUDC-101 and SAHA in Pancreatic Cancer Cells |
|
|
| Simone Moertl,Sarah Payer,Rosemarie Kell,Klaudia Winkler,Natasa Anastasov,Michael J. Atkinson |
|
| International Journal of Molecular Sciences. 2019; 20(13): 3259 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Complex interplay between tumor microenvironment and cancer therapy |
|
|
| Minhong Shen,Yibin Kang |
|
| Frontiers of Medicine. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Small molecule tyrosine kinase inhibitors and pancreatic cancer—Trials and troubles |
|
|
| Bhaskar Venkata Kameswara Subrahmanya Lakkakula,Batoul Farran,Saikrishna Lakkakula,Sujatha Peela,Nagendra Sastry Yarla,Pallaval Veera Bramhachari,Mohammad Amjad Kamal,Madhu Sudhana Saddala,Ganji Purnachandra Nagaraju |
|
| Seminars in Cancer Biology. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
dCK negatively regulates the NRF2/ARE axis and ROS production in pancreatic cancer |
|
|
| Qiangsheng Hu,Yi Qin,Jinfeng Xiang,Wensheng Liu,Wenyan Xu,Qiqing Sun,Shunrong Ji,Jiang Liu,Zheng Zhang,Quanxing Ni,Jin Xu,Xianjun Yu,Bo Zhang |
|
| Cell Proliferation. 2018; : e12456 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
The Value of Survival Gains in Pancreatic Cancer from Novel Treatment Regimens |
|
|
| Joanna P. MacEwan,Wes Yin,Satyin Kaura,Zeba M. Khan |
|
| Journal of Managed Care & Specialty Pharmacy. 2017; 23(2): 206 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
Biological determinants of radioresistance and their remediation in pancreatic cancer |
|
|
| Parthasarathy Seshacharyulu,Michael J Baine,Joshua J Souchek,Melanie Menning,Sukhwinder Kaur,Ying Yan,Michel M. Ouellette,Maneesh Jain,Chi Lin,Surinder K. Batra |
|
| Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 13 |
The role of FADD in pancreatic cancer cell proliferation and drug resistance |
|
|
| Rong Zhang,Yingting Liu,Kahina Hammache,Liangqiang He,Bo Zhu,Wei Cheng,Zi-Chun Hua |
|
| Oncology Letters. 2017; 13(3): 1899 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 14 |
Synthesis of new tricyclic thiolactams as potent antitumor agent for pancreatic cancer |
|
|
| Takuya Okada,Daisuke Minehira,Minetatsu Takada,Hirokazu Urata,Atsushi Kato,Isao Adachi,Yukiko Kurashima,Satoshi Kaji,Tsutomu Ogura,Shigeki Chiba,Hiroyasu Esumi,Naoki Toyooka |
|
| Bioorganic & Medicinal Chemistry Letters. 2016; 26(11): 2577 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 15 |
Radiation dose responses for chemoradiation therapy of pancreatic cancer: An analysis of compiled clinical data using biophysical models |
|
|
| Ion C. Moraru,An Tai,Beth Erickson,X. Allen Li |
|
| Practical Radiation Oncology. 2013; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
